• 2 Posts
  • 83 Comments
Joined vor 3 Jahren
cake
Cake day: 15. Juni 2023

help-circle



  • Ugh…this one still frustrates me a lot. If I could wave a magic wand and have a different contributor do two things for the project, animated gifs would be one and a more consistent compact layout would be the other.

    Edit: Just want to add that when I was working on the gif problem, I got it working for posts…but you have to click through into the lightbox or to the complete image url…the thumbnail isn’t animated. So, I got partway there, but ran into technical limitations of the specific python library being used. Relevant issue.


  • As somebody that has done a lot of recent work on the UI for piefed, I have tried to make sure that it works even at quite small screen sizes. I actually just submitted a couple commits in the past couple hours to make the navbar across the top of communities/feeds/topics flow smoother across different screen sizes. The PWA is so far my preferred way to use piefed.










  • Just for some background information on how most countries tend to rely on larger, more rigorous regulatory bodies…

    I am in the pharma industry (not in vaccines though). Typically the two main regulators that most other countries look to as a reference are either the FDA or the EMA (the EU organization). This usually means that if you can satisfy the requirements of one of these bodies, then it is satisfactory for the other country as well. However, it isn’t universal as each other country will usually have some modifications here and there for whatever reason. The most annoyingly particular ones I have dealt with in the past are China and Japan.



  • It’s been a while since I last used LaTeX since I am in industry now, but there is definitely a learning curve. If you are talking about undergrads, then it might be too steep a challenge for most to want to take on unless they plan on pursuing academia long-term. Like others have mentioned, LaTeX is a kind of standard that you see used a lot in academic circles. Some journals also like or support things that are created through tex and will have their own templates to use.

    Basically, LaTeX consists of writing in a markup language, like your screenshot, and then running that through a processor that interprets your .tex file and creates the formatted output (usually a pdf). Back in my day, TexnicCenter was the program of choice to write the actual .tex file, but some quick searching and it looks like VSCode with an appropriate extension is probably one of the best/easiest ways to do it now.

    The most annoying part of tex is references. I remember being utterly confused by BibTeX when I was trying to get it to work. I am way out of date on what best practices for today might be, but I hope they have improved that process somewhat.



  • I own a Prius (not a PHEV though, just a hybrid) and can corroborate that my mileage goes down significantly in the winter months. It is a combination of a couple factors in my experience.

    • Needing to run the engine more to heat things up for defrosting and heating the cabin.
    • Related to the above, I tend to idle a lot more in the winter while cleaning ice/snow off the car, letting it warm up, or clearing the driveway.
    • Switching to winter tires (Blizzaks) negatively impacts rolling resistance compared to the LRR tires (Ecopias) I use the rest of the year.

    I tend to average ~45 mpg in the summer and ~37 mpg in the winter over the past two years.




  • I work in pharma, regularly writing and filing things with the FDA (and other agencies), and this has been a topic of conversation at work. The good news for people is that the EMA is still a thing in the EU. So, at least the large pharma companies (like the one I work for), are likely to not really change much about their quality control/processes/etc. because we will still need to conform to the EMA guidelines which are typically in line with the current FDA (sometimes more strict, sometimes less so). The real quality concern would be smaller companies that only file for products in the US. They would only need to meet whatever new FDA guidelines come into effect (if they even do, changing stuff like GMP guidance is extremely complicated and time consuming) since the US is their only market.


  • Don’t overthink it. I bend the rules in my communities quite often. The case that happens most often is somebody posting a duplicate of a news story. However, it is usually one or more days later and the new post usually picks up some comments from new people that didn’t comment on the previous post. I often let those slide. As long as people are trying to constructively engage in the community, then I give people the benefit of the doubt.